Home » Tenders » Americas » USA » Tender 17980696

Department Of Defense Uniform Formulary Blanket Tender - 17980696

The OTHER DEFENSE AGENCIES has issued a Tender notice for the procurement of a Department Of Defense Uniform Formulary Blanket Purchase Agreement/ Additional Discount Program in the USA. This Tender notice was published on 06 Nov 2017 and is scheduled to close on 05 Jan 2018, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 17980696, while the tender notice number is HT9402-18-Q-0001 and Registering on the platform.

Procurement Summary

Country: USA

Summary: Department Of Defense Uniform Formulary Blanket Purchase Agreement/ Additional Discount Program

Deadline: 05 Jan 2018

Posting Date: 06 Nov 2017

Other Information

Notice Type: Tender

TOT Ref.No.: 17980696

Document Ref. No.: HT9402-18-Q-0001

Competition: ICB

Financier: Self Financed

Purchaser Ownership: -

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Tender Details

Background: the department of defense (dod) is required by law (10 u.s.c. § 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the military health system (mhs) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 cfr section 199.21) describe the process by which the dod pharmacy and therapeutics (p&t) committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the dod uniform formulary (uf) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, basic core formulary (bcf), extended core formulary (ecf), or non-formulary (nf). Prior to the scheduled p&t committee meeting, a request for quotation (rfq) for pharmaceutical agents within drug classes identified for placement on the uf has been issued to obtain quotes from industry. The defense health agency may award uniform formulary blanket purchase agreements (uf bpa) and the uniform formulary additional discount program agreements (uf adp) based on the uf decision. This process is described in the attached rfq.
P&t committee meeting: february 2018. The following drug classes/subclass and agents will be reviewed:
anti-inflammatory immunomodulatory ophthalmic agents-ophthalmic immunomodulatory agents: restasis, xiidra
diabetes non-insulin-glucagon-like peptide-1(glp-1) receptor agonists: trulicity, victoza
osteoporosis agents-pth analogues: forteo, tymlos
corticosteroids-immune modulators-adrenocorticotropic hormones: h.p. Acthar
rfq: the rfq, including uf bpa and uf adp appendices are attached herein. The historical utilization data including quantity dispensed and 30 day equivalents by month is also attached herein.
Pre-proposal conference: see paragraphs 2.4 and 2.5 of the rfq. Minutes will be posted herein.
Clinical presentations: interested p...

Documents

Tender Notice

Browse More

All Tenders From USA

All Tenders From Americas

Procurement Documents for USA

Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA

Explore Procurement Documents for USA

Want To Bid in This Tender?

Get Local Agent Support in USA and 60 More Countries.

View All The Services

View Tenders By